Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **SLC4 family of bicarbonate transporter** (abbreviated **SLC4**) consists of multiple integral membrane proteins mediating the transport of bicarbonate (HCO₃⁻), chloride (Cl⁻), sodium (Na⁺), and carbonate (CO₃²⁻) across plasma membranes[1][2][4]. This family includes both **anion exchangers** (typically exchanging Cl⁻ and HCO₃⁻, such as AE1–3, and AE4) and **sodium-coupled bicarbonate cotransporters** (such as NBCe1, NBCe2, NBCn1, NBCn2, and NDCBE), which may be electroneutral or electrogenic depending on their stoichiometry[1][2][5][6]. SLC4 proteins are critical for **systemic and cellular pH regulation**, homeostasis of acid-base balance, and play vital roles in processes like **neutralization of gastric acid, renal acid-base transport, CO₂ carriage by red blood cells**, and **mineralization in calcifying cells**. Genetic and functional alterations in these transporters are linked to a range of **human diseases**, including **metabolic acidosis, renal tubular acidosis, cardiovascular and neurological conditions**, as well as disorders of biomineralization[2][4][5][7]. The family is a pharmacological target mainly for research, with **DIDS** and related stilbene derivatives being the principal inhibitors used experimentally. Most SLC4 proteins are composed of 10–14 predicted transmembrane segments and often function as dimers or higher-order oligomers[1][3].
Inhibition of ion transport (e.g., DIDS inhibits Cl⁻/HCO₃⁻ exchange) Modulation of acid-base transport and cellular pH via altered ion exchange or cotransport
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC4 family of bicarbonate transporter (SLC4).